Literature DB >> 31586545

Even Cancer Cells Watch Their Cholesterol!

Romain Riscal1, Nicolas Skuli1, M Celeste Simon2.   

Abstract

Deregulated cell proliferation is an established feature of cancer, and altered tumor metabolism has witnessed renewed interest over the past decade, including the study of how cancer cells rewire metabolic pathways to renew energy sources and "building blocks" that sustain cell division. Microenvironmental oxygen, glucose, and glutamine are regarded as principal nutrients fueling tumor growth. However, hostile tumor microenvironments render O2/nutrient supplies chronically insufficient for increased proliferation rates, forcing cancer cells to develop strategies for opportunistic modes of nutrient acquisition. Recent work shows that cancer cells overcome this nutrient scarcity by scavenging other substrates, such as proteins and lipids, or utilizing adaptive metabolic pathways. As such, reprogramming lipid metabolism plays important roles in providing energy, macromolecules for membrane synthesis, and lipid-mediated signaling during cancer progression. In this review, we highlight more recently appreciated roles for lipids, particularly cholesterol and its derivatives, in cancer cell metabolism within intrinsically harsh tumor microenvironments.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bile acids; cancer; cholesterol; lipids; metabolism; oxysterols

Mesh:

Substances:

Year:  2019        PMID: 31586545     DOI: 10.1016/j.molcel.2019.09.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  35 in total

1.  Squalene and cholesterol in the balance at the ER membrane.

Authors:  James A Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-01       Impact factor: 11.205

2.  Can increased expression of miR-Let-7c reduce the transition potential of high-grade urothelial carcinoma?

Authors:  Paulo Ricardo da Silva Gomes; Patricia Candido; Vitória Ghazarian; Juliana A Camargo; Vanessa R Guimarães; Guilherme L Gonçalves; Poliana Romão; Iran A Silva; Miguel Srougi; William C Nahas; Kátia R Leite; Sabrina T Reis; Ruan Pimenta; Nayara Izabel Viana
Journal:  Mol Biol Rep       Date:  2021-10-27       Impact factor: 2.316

3.  Mechanoregulation of Metastasis beyond the Matrix.

Authors:  Ekrem Emrah Er; Maria Tello-Lafoz; Morgan Huse
Journal:  Cancer Res       Date:  2022-10-04       Impact factor: 13.312

Review 4.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

5.  Chemical Exchange Saturation Transfer (CEST) Signal at -1.6 ppm and Its Application for Imaging a C6 Glioma Model.

Authors:  Qi-Xuan Wu; Hong-Qing Liu; Yi-Jiun Wang; Tsai-Chen Chen; Zi-Ying Wei; Jung-Hsuan Chang; Ting-Hao Chen; Jaya Seema; Eugene C Lin
Journal:  Biomedicines       Date:  2022-05-24

6.  Stromal CAVIN1 Controls Prostate Cancer Microenvironment and Metastasis by Modulating Lipid Distribution and Inflammatory Signaling.

Authors:  Jin-Yih Low; W Nathaniel Brennen; Alan K Meeker; Elina Ikonen; Brian W Simons; Marikki Laiho
Journal:  Mol Cancer Res       Date:  2020-06-03       Impact factor: 5.852

7.  Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma.

Authors:  Xing Xu; Jun Chen; Yan Li; Xiaojie Yang; Qing Wang; Yanjun Wen; Ming Yan; Jianjun Zhang; Qin Xu; Yan Wei; Wantao Chen; Xu Wang
Journal:  Cell Death Dis       Date:  2021-05-13       Impact factor: 8.469

Review 8.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

9.  The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.

Authors:  Francesco Rugolo; Nicolas G Bazan; Jorgelina Calandria; Bokkyoo Jun; Giuseppe Raschellà; Gerry Melino; Massimiliano Agostini
Journal:  Oncogene       Date:  2021-07-31       Impact factor: 9.867

10.  Maprotiline Suppresses Cholesterol Biosynthesis and Hepatocellular Carcinoma Progression Through Direct Targeting of CRABP1.

Authors:  Cancan Zheng; Yidong Zhu; Qinwen Liu; Tingting Luo; Wenwen Xu
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.